June 26, 2018
Of all the ways the industries that the smartphone has unalterably changed, some of the most fascinating results are in the ways it has shifted how people view their responsibility for their own health.
Not only have more than half of all smartphone users downloaded a mobile health app for things like weight loss, exercise and pregnancy, but smartphones have also led to an increase in at-home testing for everything from blood tests to STD screenings to cancer detection, cutting down on the need for patients to see a doctor to perform routine tests, saving time and money on both ends.
EyeQue is a company providing that same service for, as its name suggests, eye tests. It sells a direct to consumer smartphone attachment that allows users to take vision tests that can measure their refraction to see if they need glasses, and another that can test eye performance.
On Tuesday, the company announced that it raised $11.2 million in a Series B round, bringing its total funding to $16.2 million. Investors in the round, all of whom had previously put funding into EyeQue, were unnamed.
Founded in 2015, EyeQue was started with the goal of providing low cost, but also accurate, vision tests to people around the world, especially to those who don’t have access to a doctor.
Read more > VatorNews
Financial trends and news by Steven Loeb
June 26, 2018
Short URL: http://vator.tv/n/4bb4